Enanta Pharmaceuticals, Inc. (ENTA) CEO Jay Luly on Q3 2022 Results - Earnings Call Transcript
Enanta Pharmaceuticals, Inc. (ENTA) CEO Jay Luly on Q3 2022 Results - Earnings Call Transcript
SeekingAlpha
0 shares
1 views
You might like
Related news coverage
-
Elite Pharmaceuticals, Inc. (ELTP) CEO Nasrat Hakim on Q1 2023 Results - Earnings Call Transcript
SeekingAlpha
-
Acurx Pharmaceuticals, Inc. (ACXP) CEO David Luci on Q2 2022 Results - Earnings Call Transcript
SeekingAlpha
-
Acumen Pharmaceuticals, Inc. (ABOS) CEO Daniel O'Connell on Q2 2022 Results - Earnings Call Transcript
SeekingAlpha
-
NRx Pharmaceuticals, Inc. (NRXP) CEO Stephen Willard on Q2 2022 Results - Earnings Call Transcript
SeekingAlpha
Advertisement
More coverage
-
Processa Pharmaceuticals, Inc. (PCSA) CEO David Young on Q2 2022 Results - Earnings Call Transcript
SeekingAlpha
-
BioAtla, Inc. (BCAB) CEO Jay Short on Q2 2022 Results - Earnings Call Transcript
SeekingAlpha
-
Cumberland Pharmaceuticals Inc. (CPIX) CEO A.J. Kazimi on Q2 2022 Results - Earnings Call Transcript
SeekingAlpha
-
Kala Pharmaceuticals, Inc. (KALA) CEO Mark Iwicki on Q2 2022 Results - Earnings Call Transcript
SeekingAlpha